Protalix BioTherapeutics (PLX)
Protalix BioTherapeutics Balance Sheet
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Assets | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Cash & Short Term Investments | 45.60M | 27.00M | 34.56M | 44.05M | 50.23M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Receivables | 3.969M | 5.211M | 5.291M | 6.604M | 10.93M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Inventory | 0.263M | 0.279M | 0.427M | 0.537M | 1.101M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Prepaid Expenses | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Current Assets | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Current Assets | 49.84M | 32.49M | 40.28M | 51.20M | 62.25M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Gross Property, Plant & Equipment | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Accumulated Depreciation | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Property, Plant & Equipment | 17.51M | 18.27M | 18.51M | 18.94M | 17.65M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Long Term Investments | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Goodwill & Intangibles | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Long Term Assets | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Long Term Assets | 18.63M | 19.31M | 20.55M | 20.69M | 18.67M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Assets | 68.46M | 51.80M | 60.83M | 71.89M | 80.92M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Liabilities | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Current Portion of Long Term Debt | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Accounts Payable | 12.87M | 12.57M | 12.68M | 14.14M | 15.57M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Accrued Expenses | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Deferred Revenues | 4.858M | 6.121M | 5.633M | 6.146M | 4.563M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Current Liabilities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Current Liabilities | 17.72M | 18.69M | 18.31M | 20.28M | 20.13M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Long Term Debt | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Shareholder's Equity | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Deferred Income Tax | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Minority Interest | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Long Term Liabilities | 5.623M | 6.566M | 4.738M | 4.452M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Total Long Term Liabilities | 57.20M | 59.19M | 59.87M | 60.31M | 56.09M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Liabilities | 74.92M | 77.88M | 78.18M | 80.59M | 76.22M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Common Shares Outstanding | 90.82M | 85.63M | 85.60M | 80.84M | 85.58M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Preferred Stock | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Common Stock, Net | 0.091M | 0.086M | 0.086M | 0.086M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Additional Paid-in Capital | 171.33M | 145.81M | 145.62M | 145.12M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Retained Earnings | -177.88M | -171.98M | -163.06M | -140.50M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |
| Treasury Stock | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Shareholder's Equity | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Shareholder's Equity | -6.457M | -26.08M | -17.35M | -8.703M | 4.705M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Liabilities & Shareholder's Equity | 68.46M | 51.80M | 60.83M | 71.89M | 80.92M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
